(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -1.62%4.03B | -5.03%8.2B | -3.93%4.1B | 3.52%8.64B | 12.87%4.27B | 66.02%8.34B | 141.53%3.78B | 101.91%5.03B | 85.08%1.56B | 87.24%2.49B |
Operating income | -1.62%4.03B | -5.03%8.2B | -3.93%4.1B | 3.52%8.64B | 12.87%4.27B | 66.02%8.34B | 141.53%3.78B | 101.91%5.03B | 85.08%1.56B | 87.24%2.49B |
Cost of sales | 0.47%-3.22B | 2.06%-6.56B | -2.65%-3.24B | -12.44%-6.69B | -24.89%-3.15B | -72.66%-5.95B | -144.35%-2.52B | -108.84%-3.45B | -83.44%-1.03B | -75.82%-1.65B |
Operating expenses | 0.47%-3.22B | 2.06%-6.56B | -2.65%-3.24B | -12.44%-6.69B | -24.89%-3.15B | -72.66%-5.95B | -144.35%-2.52B | -108.84%-3.45B | -83.44%-1.03B | -75.82%-1.65B |
Gross profit | -5.93%811.51M | -15.26%1.65B | -22.53%862.67M | -18.71%1.94B | -11.29%1.11B | 51.49%2.39B | 136.06%1.26B | 88.26%1.58B | 88.36%531.8M | 114.73%838.08M |
Selling expenses | 5.86%-59.55M | 41.48%-136.64M | 41.01%-63.26M | -26.66%-233.49M | -122.39%-107.24M | -251.50%-184.34M | -143.86%-48.22M | -194.25%-52.44M | -287.19%-19.77M | -177.79%-17.82M |
Administrative expenses | 6.65%-418.86M | 27.05%-989.52M | 4.58%-448.69M | -96.88%-1.36B | -12.99%-470.2M | -22.52%-688.99M | -105.04%-416.13M | -85.04%-562.34M | -59.04%-202.96M | -57.79%-303.91M |
Revaluation surplus | ---- | ---- | ---- | -99.96%57K | --57K | --144.75M | ---- | ---- | ---- | ---- |
-Changes in the fair value of derivative financial instruments | ---- | ---- | ---- | -99.96%57K | --57K | --144.75M | ---- | ---- | ---- | ---- |
Impairment and provision | -561.18%-86.52M | 85.85%-207.91M | 96.75%-13.09M | -485.03%-1.47B | -220.11%-402.8M | -256.10%-251.15M | -1,631.10%-125.83M | -1,991.55%-70.53M | -12.35%-7.27M | 60.84%-3.37M |
-Impairment of intangible assets | ---- | 83.28%-121.32M | ---- | ---725.62M | ---- | ---- | ---- | ---- | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---22.59M | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | -561.18%-86.52M | 88.36%-86.6M | 96.56%-13.09M | -196.10%-743.66M | -202.15%-380.21M | -256.10%-251.15M | -1,631.10%-125.83M | -1,991.55%-70.53M | -12.35%-7.27M | 60.84%-3.37M |
Special items of operating profit | 107.90%5.45M | -89.81%31.21M | -137.27%-68.94M | 222.75%306.41M | 172.93%184.96M | 1,959.39%94.94M | 448.79%67.77M | -43.63%4.61M | 1,669.20%12.35M | 143.68%8.18M |
Operating profit | -6.21%252.03M | 142.43%343.57M | -15.61%268.71M | -153.80%-809.79M | -56.56%318.4M | 67.80%1.51B | 133.31%732.93M | 72.13%897.05M | 118.40%314.15M | 180.16%521.16M |
Financing income | -30.37%22.12M | 43.01%78.11M | -13.28%31.76M | 77.47%54.62M | 202.69%36.63M | 169.79%30.78M | 360.78%12.1M | -69.93%11.41M | -88.10%2.63M | -50.13%37.94M |
Financing cost | 2.00%-19.17M | 78.76%-45.93M | 85.62%-19.56M | -302.33%-216.3M | -1,200.13%-135.99M | -268.55%-53.76M | 21.11%-10.46M | 71.86%-14.59M | 35.05%-13.26M | 22.52%-51.83M |
Share of profits of associates | 88.25%7.05M | -5.07%12.1M | 23.15%3.75M | -4.83%12.75M | 49.36%3.04M | 22.73%13.4M | 1,640.17%2.04M | 1,003.56%10.92M | 200.86%117K | ---1.21M |
Earning before tax | -7.95%262.03M | 140.45%387.85M | 28.18%284.65M | -164.10%-958.72M | -69.85%222.07M | 65.31%1.5B | 142.60%736.61M | 78.79%904.79M | 108.86%303.63M | 159.26%506.05M |
Tax | 36.57%-51.19M | -186.65%-71.1M | -122.61%-80.7M | 129.42%82.05M | 62.83%-36.25M | -54.52%-278.86M | -99.20%-97.53M | -48.51%-180.47M | -34.16%-48.96M | -148.05%-121.52M |
After-tax profit from continuing operations | 3.38%210.84M | 136.13%316.75M | 9.76%203.95M | -172.04%-876.67M | -70.92%185.82M | 68.00%1.22B | 150.94%639.08M | 88.36%724.32M | 133.90%254.67M | 163.02%384.53M |
Earning after tax | 3.38%210.84M | 136.13%316.75M | 9.76%203.95M | -172.04%-876.67M | -70.92%185.82M | 68.00%1.22B | 150.94%639.08M | 88.36%724.32M | 133.90%254.67M | 163.02%384.53M |
Minority profit | -45.34%26.87M | -13.77%43.5M | 6.41%49.17M | -52.59%50.45M | -24.16%46.21M | 239.22%106.4M | 558.57%60.92M | --31.37M | --9.25M | ---- |
Profit attributable to shareholders | 18.86%183.97M | 129.47%273.25M | 10.86%154.78M | -183.49%-927.12M | -75.85%139.61M | 60.25%1.11B | 135.58%578.16M | 80.21%692.95M | 125.40%245.42M | 163.02%384.53M |
Basic earnings per share | 17.30%0.0746 | 128.95%0.11 | 12.37%0.0636 | -182.61%-0.38 | -76.42%0.0566 | 35.29%0.46 | 100.00%0.24 | 78.95%0.34 | -99.99%0.12 | -99.99%0.19 |
Diluted earnings per share | 17.19%0.0743 | 128.95%0.11 | 12.21%0.0634 | -182.61%-0.38 | -76.46%0.0565 | 35.29%0.46 | 100.00%0.24 | 78.95%0.34 | -99.99%0.12 | -99.99%0.19 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data